(lp0
S"Why Arrowhead Pharmaceuticals Inc. Is Plummeting Today Motley Fool - Nov 9, 2016 Arrowhead stated that the U.S. Food and Drug Administration has verbally notified the company of the agency's decision to place a study called Heparc-2004 on hold.Arrowhead Stock Falls After FDA Places Hold on Clinical Trial - Xconomy"
p1
aS"Here's Why Arrowhead Pharmaceuticals Inc. Is Being Obliterated Today Motley Fool - Nov 30, 2016 It is a rough day to be an investor in Arrowhead Pharmaceuticals . Shares of the clinical-stage biotech are collapsing, falling more than 65% as of 11:36 a.m.Stock Update : Here's Why Shares of Arrowhead Pharmaceuticals Inc ... - Smarter Analyst"
p2
aS"What's Next for Arrowhead Pharmaceuticals, Inc. After the Stock Meltdown? Motley Fool - Nov 10, 2016 Things had been looking pretty good for Arrowhead Pharmaceuticals, Inc.  this year. Not anymore. Shares of the biotech plunged over 30% on Wednesday after the U.S.Chardan Weighs in on Biotech Stocks Novavax, Inc.  and Arrowhead ... - Smarter AnalystArrowhead Pharmaceuticals' Clinical Hold Woes Are Overblown - Seeking Alpha"
p3
aS'Company Update : Arrowhead Pharmaceuticals Inc Reports FQ1:17 Results Smarter Analyst - Feb 6, 2017 The 12-month average price target assigned to the stock is $2.00, which represents a slight upside potential from current levels. Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline&nbsp;...Arrowhead Pharmaceuticals, Inc.  Posts Quarterly Earnings Results - Sports Perspectives'
p4
aS'Investor Watch on These Shares: Arrowhead Pharmaceuticals Inc  Rives Journal - 15 hours ago Technical Traders may be interested in looking at the indicator levels on shares of Arrowhead Pharmaceuticals Inc . The 14-day ADX for Arrowhead Pharmaceuticals Inc  is currently 50.14. In general, an ADX value from 0-25 would signal an&nbsp;...'
p5
aS'Analyst Downgrades: Arrowhead Pharmaceuticals Inc, Freeport-McMoRan Inc, and ... Schaeffers Research  - Nov 30, 2016 Analysts are weighing in on drugmaker Arrowhead Pharmaceuticals Inc , mining stock Freeport-McMoRan Inc , and real estate specialist Fang Holdings Ltd .'
p6
aS'Arrowhead Pharmaceuticals, Inc.  held by 19 SEC 13F Filers Post Analyst - 57 minutes ago Arrowhead Pharmaceuticals, Inc.  reached 73.33% versus a 1-year low price of $1.2. The stock was last seen -1.89% lower, reaching at $2.08 on Mar. 14, 2017.Arrowhead Pharmaceuticals, Inc. : VC in The Spotlight - TCT'
p7
aS'Cantor Reiterates Buy on Arrowhead Pharmaceuticals Inc Following Clinical ... Smarter Analyst - Sep 8, 2016 In a research report issued yesterday, Cantor analyst Elemer Piros reiterated a Buy rating on shares of Arrowhead Pharmaceuticals Inc , with a price target of $15.00, after the biotech firm announced the initiation of the multiple ...'
p8
aS'Cantor Sees 100% Upside for Arrowhead Pharmaceuticals Inc  Shares Smarter Analyst - Aug 19, 2016 Cantor analyst Elemer Piros initiated coverage on shares of Arrowhead Pharmaceuticals Inc , with a Buy rating and price target of $15, which represents a 100% increase from where the shares last closed.What Caused Arrowhead Pharmaceuticals to Skyrocket 12.5% Today - Motley FoolArrowhead Pharmaceuticals Inc.  Continues Upward Journey - Scibility Media'
p9
aS'Arrowhead Pharmaceuticals Inc.  Soars 10.86% on January 31 Equities.com - Jan 31, 2017 Arrowhead Pharmaceuticals Inc.  had a good day on the market for Tuesday January 31 as shares jumped 10.86% to close at $1.94.'
p10
a.